Abbott Laboratories (NYSE:ABT) to go ex-dividend.On 6/8/2018 Abbott Laboratories ( NYSE:ABT ) announced that it will be issuing a quarterly dividend in the amount of $0.28 down from $0.28 making the yield 1.78%.Abbott Laboratories (NYSE:ABT) Ex- dividend dateAbbott Laboratories (NYSE:ABT) is set to go ex-dividend on and will be payable on 8/15/2018 Dividend History for Abbott Laboratories (NYSE:ABT) The next payable dividend for Abbott Laboratories is scheduled for 8/15/2018. There is an annual dividend of $$1.12 with a yield of 1.77% The company’s dividend has increased by 6.40% on a 3 Year AverageRecent Dividend History for Abbott Laboratories (NYSE:ABT)
- On 12/14/2012 Abbott Laboratories announced a quarterly dividend of $0.14.
- On 2/15/2013 Abbott Laboratories announced a quarterly dividend of $0.14.
- On 6/14/2013 Abbott Laboratories announced a quarterly dividend of $0.14.
- On 9/12/2013 Abbott Laboratories announced a quarterly dividend of $0.14.
- On 10/16/2013 Abbott Laboratories announced a quarterly dividend of $0.22.
- On 2/21/2014 Abbott Laboratories announced a quarterly dividend of $0.22.
Recent Insider Trading for Abbott Laboratories (NYSE:ABT)
- On 5/18/2018 Daniel Gesua Sive Salvadori, Insider, sold 3,000 with an average share price of $61.20 per share and the total transaction amounting to $183,600.00.
- On 5/4/2018 Sharon J Bracken, SVP, sold 2,150 with an average share price of $58.56 per share and the total transaction amounting to $125,904.00.
- On 4/23/2018 Jaime Contreras, Insider, sold 849 with an average share price of $59.36 per share and the total transaction amounting to $50,396.64.
- On 3/9/2018 Roger Bird, Insider, sold 8,262 with an average share price of $62.75 per share and the total transaction amounting to $518,440.50.
- On 3/7/2018 Jared Watkin, Insider, sold 3,000 with an average share price of $61.19 per share and the total transaction amounting to $183,570.00.
- On 3/5/2018 Sharon J Bracken, SVP, sold 2,100 with an average share price of $60.27 per share and the total transaction amounting to $126,567.00.
Recent Analyst Rating for Abbott Laboratories (NYSE:ABT)
- On 4/24/2018 Citigroup, Lower Price Target, to Neutral ➝ Neutral with a price target of $66.00 ➝ $65.00
- On 4/22/2018 BTIG Research, Reiterated Rating, to Hold
- On 1/30/2018 Argus, Boost Price Target, to bought with a price target of $66.00 ➝ $80.00
- On 1/25/2018 Barclays, Boost Price Target, to Overweight ➝ Overweight with a price target of $66.00 ➝ $70.00
- On 1/25/2018 Guggenheim, Reiterated Rating, to bought with a price target of $72.00
- On 1/25/2018 Royal Bank of Canada, Reiterated Rating, to bought with a price target of $67.00
Recent Trading for Abbott Laboratories (NYSE:ABT) Shares of Abbott Laboratories closed the previous trading session at 63.20 up +0.02 0.03% with 63.40999984741211 shares trading hands.